Liquidia (LQDA) Current Leases (2019 - 2026)
Liquidia's (LQDA) quarterly Current Leases came in at $807000.0 in Q1 2026, up 114.06% year-on-year from $377000.0 in Q1 2025, and up 65.71% quarter-over-quarter from $487000.0 in Q4 2025.
Liquidia (LQDA) Current Leases (2019 - 2026) Analysis & Trends
Liquidia's Current Leases history runs 8 years deep, the most recent figure standing at $807000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 114.06% year-over-year to $807000.0 in Q1 2026; TTM through Mar 2026 was $807000.0, a 114.06% increase from a year earlier, with the FY2025 full-year figure at $487000.0, up 16.79% from the prior year.
- Current Leases advanced to $807000.0 in Q1 2026 per LQDA's latest filing, from $487000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.2 million in Q3 2024 and bottomed at $104000.0 in Q2 2023.
- The 5-year median for Current Leases is $807000.0 (2026), against an average of $742941.2.
- Across the five-year window, Current Leases jumped 1077.88% in 2024 and slumped 68.95% in 2025, its largest moves.
- Year by year, Current Leases stood at $900000.0 in 2022, then grew by 26.56% to $1.1 million in 2023, then sank by 63.39% to $417000.0 in 2024, then advanced by 16.79% to $487000.0 in 2025, then jumped by 65.71% to $807000.0 in 2026.
- Per Business Quant, the three latest LQDA Current Leases figures stand at $807000.0 (Q1 2026), $487000.0 (Q4 2025), and $428000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 807,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 807,000.00 |
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Jun 30, 2025 | 402,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 417,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 999,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 932,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Sep 30, 2022 | 865,000.00 |
| Jun 30, 2022 | 281,000.00 |
| Mar 31, 2022 | 804,000.00 |
| Dec 31, 2021 | 311,000.00 |
| Sep 30, 2021 | 745,891.00 |
| Jun 30, 2021 | 718,223.00 |